Header Logo

ROBIN PARIHAR

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address6701 FANNIN
vCardDownload vCard

    Collapse Biography 
    Collapse awards and honors
    2002Aventis Oncology Scholar-in-Training Award, American Association for Cancer Research (AACR)
    2003Dissertation Research Award, Susan G Komen Breast Cancer Foundation
    2004Takeda Pharmaceuticals Scholar-in-Training Award, American Association for Cancer Research (AACR)
    2011Trainee Research Award, American Society of Hematology (ASH)
    20151st-place Research Poster Award, Texas Children's Cancer Center Research Symposium, Baylor College of Medicine
    2015Faculty Teaching Award, Center for Cell and Gene Therapy, Texas Children's Hospital and Baylor College of Medicine
    2018Young Investigator Award, American Society for Pediatric Hematology/Oncology (ASPHO)
    2018Distinguished Young Investigator Research Award, SITC Immuno-Oncology Young Investigators’ Forum

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fetzko SL, Timothy LD, Parihar R. NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition. Curr Hematol Malig Rep. 2023 12; 18(6):264-272. PMID: 37751103.
      Citations:    Fields:    Translation:HumansCells
    2. Navin I, PARIHAR R. Reversing the NK inhibitory tumor microenvironment by targeting suppressive immune effectors. NK Cells in Cancer Immunotherapy: Successes and Challenges. 2023; 27-63. View Publication.
    3. Parihar R. Memory NK cells to forget relapsed AML. Blood. 2022 03 17; 139(11):1607-1608. PMID: 35298605.
      Citations:    Fields:    Translation:HumansCells
    4. Nalawade SA, Shafer P, Bajgain P, McKenna MK, Ali A, Kelly L, Joubert J, Gottschalk S, Watanabe N, Leen A, Parihar R, Vera Valdes JF, Hoyos V. Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. J Immunother Cancer. 2021 11; 9(11). PMID: 34815355; PMCID: PMC8611441.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    5. Rosewell Shaw A, Porter CE, Yip T, Mah WC, McKenna MK, Dysthe M, Jung Y, Parihar R, Brenner MK, Suzuki M. Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors. Commun Biol. 2021 03 19; 4(1):368. PMID: 33742099; PMCID: PMC7979740.
      Citations: 7     Translation:HumansCells
    6. Navin I, Lam MT, Parihar R. Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment. Cancers (Basel). 2020 Dec 21; 12(12). PMID: 33371456; PMCID: PMC7767468.
      Citations: 6     
    7. Devkota L, Starosolski Z, Rivas CH, Stupin I, Annapragada A, Ghaghada KB, Parihar R. Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics. Sci Adv. 2020 07; 6(28):eaba6156. PMID: 32832602; PMCID: PMC7439308.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    8. Dysthe M, Parihar R. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Adv Exp Med Biol. 2020; 1224:117-140. PMID: 32036608.
      Citations: 39     Fields:    Translation:HumansCells
    9. Parihar R, Rivas C, Huynh M, Omer B, Lapteva N, Metelitsa LS, Gottschalk SM, Rooney CM. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors. Cancer Immunol Res. 2019 03; 7(3):363-375. PMID: 30651290; PMCID: PMC7906796.
      Citations: 83     Fields:    Translation:HumansAnimalsCells
    10. Omer B, Castillo PA, Tashiro H, Shum T, Huynh MTA, Cardenas M, Tanaka M, Lewis A, Sauer T, Parihar R, Lapteva N, Schmueck-Henneresse M, Mukherjee M, Gottschalk S, Rooney CM. Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells. Front Med (Lausanne). 2018; 5:343. PMID: 30619856; PMCID: PMC6297364.
      Citations: 3     
    11. Jayaraman P, Parikh F, Newton JM, Hanoteau A, Rivas C, Krupar R, Rajapakshe K, Pathak R, Kanthaswamy K, MacLaren C, Huang S, Coarfa C, Spanos C, Edwards DP, Parihar R, Sikora AG. TGF-?1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy. Oncoimmunology. 2018; 7(10):e1490853. PMID: 30288358; PMCID: PMC6169570.
      Citations: 19     Fields:    
    12. Shum T, Omer B, Tashiro H, Kruse RL, Wagner DL, Parikh K, Yi Z, Sauer T, Liu D, Parihar R, Castillo P, Liu H, Brenner MK, Metelitsa LS, Gottschalk S, Rooney CM. Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discov. 2017 11; 7(11):1238-1247. PMID: 28830878; PMCID: PMC5669830.
      Citations: 93     Fields:    Translation:HumansAnimalsCells
    13. Campbell AR, Duggan MC, Suarez-Kelly LP, Bhave N, Opheim KS, McMichael EL, Trikha P, Parihar R, Luedke E, Lewis A, Yung B, Lee R, Raulet D, Tridandapani S, Groh V, Yu L, Yildiz V, Byrd JC, Caligiuri MA, Carson WE. MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions. Cancer Immunol Res. 2017 09; 5(9):778-789. PMID: 28724544; PMCID: PMC5581690.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    14. Parihar R. Sensing Bad: Are Co-stimulatory CAR-Expressing ?d T Cells Safer? Mol Ther. 2017 05 03; 25(5):1064-1066. PMID: 28433402; PMCID: PMC5417836.
      Citations: 1     Fields:    Translation:Cells
    15. Lapteva N, Parihar R, Rollins LA, Gee AP, Rooney CM. Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy. Methods Mol Biol. 2016; 1441:195-202. PMID: 27177667.
      Citations: 8     Fields:    Translation:HumansCells
    16. Campbell AR, Regan K, Bhave N, Pattanayak A, Parihar R, Stiff AR, Trikha P, Scoville SD, Liyanarachchi S, Kondadasula SV, Lele O, Davuluri R, Payne PR, Carson WE. Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12. BMC Med Genomics. 2015 Oct 15; 8:66. PMID: 26470881; PMCID: PMC4608307.
      Citations: 13     Fields:    Translation:HumansCells
    17. Jaime-Ramirez AC, Mundy-Bosse BL, Kondadasula S, Jones NB, Roda JM, Mani A, Parihar R, Karpa V, Papenfuss TL, LaPerle KM, Biller E, Lehman A, Chaudhury AR, Jarjoura D, Burry RW, Carson WE. IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-? production. J Immunol. 2011 Mar 15; 186(6):3401-9. PMID: 21321106; PMCID: PMC3593307.
      Citations: 49     Fields:    Translation:AnimalsCells
    18. Kondadasula SV, Roda JM, Parihar R, Yu J, Lehman A, Caligiuri MA, Tridandapani S, Burry RW, Carson WE. Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. Blood. 2008 Apr 15; 111(8):4173-83. PMID: 18174382; PMCID: PMC2288725.
      Citations: 48     Fields:    Translation:HumansCells
    19. Roda JM, Parihar R, Lehman A, Mani A, Tridandapani S, Carson WE. Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol. 2006 Jul 01; 177(1):120-9. PMID: 16785506.
      Citations: 56     Fields:    Translation:HumansAnimalsCells
    20. Roda JM, Parihar R, Magro C, Nuovo GJ, Tridandapani S, Carson WE. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res. 2006 Jan 01; 66(1):517-26. PMID: 16397268.
      Citations: 60     Fields:    Translation:HumansAnimalsCells
    21. Eisenbeis CF, Lesinski GB, Anghelina M, Parihar R, Valentino D, Liu J, Nadella P, Sundaram P, Young DC, Sznol M, Walker MJ, Carson WE. Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12. J Clin Oncol. 2005 Dec 01; 23(34):8835-44. PMID: 16314644.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    22. Parihar R, Trotta R, Roda JM, Ferketich AK, Tridandapani S, Caligiuri MA, Carson WE. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12. Cancer Res. 2005 Oct 01; 65(19):9099-107. PMID: 16204085.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    23. Roda JM, Parihar R, Carson WE. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. J Immunol. 2005 Aug 01; 175(3):1619-27. PMID: 16034101.
      Citations: 45     Fields:    Translation:HumansAnimalsCells
    24. Parihar R, Carson WE. Novel cytokines in the treatment of malignancies. Cancer Treat Res. 2005; 126:353-73. PMID: 16209074.
      Citations: 1     Fields:    Translation:Humans
    25. Trotta R, Parihar R, Yu J, Becknell B, Allard J, Wen J, Ding W, Mao H, Tridandapani S, Carson WE, Caligiuri MA. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood. 2005 Apr 15; 105(8):3011-8. PMID: 15604218.
      Citations: 43     Fields:    Translation:HumansAnimalsCells
    26. Sussman JJ, Parihar R, Winstead K, Finkelman FD. Prolonged culture of vaccine-primed lymphocytes results in decreased antitumor killing and change in cytokine secretion. Cancer Res. 2004 Dec 15; 64(24):9124-30. PMID: 15604282.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    27. Parihar R, Nadella P, Lewis A, Jensen R, De Hoff C, Dierksheide JE, VanBuskirk AM, Magro CM, Young DC, Shapiro CL, Carson WE. A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin Cancer Res. 2004 Aug 01; 10(15):5027-37. PMID: 15297404.
      Citations: 56     Fields:    Translation:HumansCellsCTClinical Trials
    28. Lesinski GB, Anghelina M, Zimmerer J, Bakalakos T, Badgwell B, Parihar R, Hu Y, Becknell B, Abood G, Chaudhury AR, Magro C, Durbin J, Carson WE. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest. 2003 Jul; 112(2):170-80. PMID: 12865406; PMCID: PMC164283.
      Citations: 42     Fields:    Translation:AnimalsCells
    29. Dakappagari NK, Pyles J, Parihar R, Carson WE, Young DC, Kaumaya PT. A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses. J Immunol. 2003 Apr 15; 170(8):4242-53. PMID: 12682258.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    30. Fleming GF, Meropol NJ, Rosner GL, Hollis DR, Carson WE, Caligiuri M, Mortimer J, Tkaczuk K, Parihar R, Schilsky RL, Ratain MJ. A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clin Cancer Res. 2002 Dec; 8(12):3718-27. PMID: 12473581.
      Citations: 16     Fields:    Translation:HumansCellsCTClinical Trials
    31. Parihar R, Dierksheide J, Hu Y, Carson WE. IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. J Clin Invest. 2002 Oct; 110(7):983-92. PMID: 12370276; PMCID: PMC151155.
      Citations: 111     Fields:    Translation:HumansAnimalsCells
    32. Badgwell B, Parihar R, Magro C, Dierksheide J, Russo T, Carson WE. Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery. 2002 Aug; 132(2):205-12. PMID: 12219013.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    33. Biber JL, Jabbour S, Parihar R, Dierksheide J, Hu Y, Baumann H, Bouchard P, Caligiuri MA, Carson W. Administration of two macrophage-derived interferon-gamma-inducing factors (IL-12 and IL-15) induces a lethal systemic inflammatory response in mice that is dependent on natural killer cells but does not require interferon-gamma. Cell Immunol. 2002 Mar-Apr; 216(1-2):31-42. PMID: 12381348.
      Citations: 3     Fields:    Translation:AnimalsCells
    PARIHAR's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (204)
    Explore
    _
    Co-Authors (26)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _